Blood sugar can dangerously affect heart rate

IN BRIEF

• Significant drops in blood glucose (hypoglycemia) can alter heart rate and rhythm; this association is documented in both clinical studies and experimental models.
• Nocturnal episodes tend to be more prolonged and less symptomatic; some research links nocturnal hypoglycemia with bradycardia and arrhythmias.
• Evidence indicates an association between hypoglycemia and increased cardiovascular risks, but the direct causal relationship remains complex and depends on the clinical context.
• The risk increases in people with diabetes who take insulin or hypoglycemic medications, and in those with cardiovascular disease or autonomic neuropathy.
• Monitoring technologies (CGM) help identify nocturnal episodes; therapeutic choices should always be personalized with a doctor.

Abstract: what does science say?

Blood sugar, or glycemia, influences various physiological functions, including heart rate and rhythm control. Clinical and experimental evidence documents that hypoglycemia can produce electrophysiological alterations (QT prolongation, changes in heart rate variability) and modulate the autonomic nervous system, with possible episodes of bradycardia or arrhythmias. Nocturnal episodes are often longer and less perceived, with a different autonomic profile compared to daytime. However, the literature shows variability: some observational studies report associations with increased cardiovascular mortality, while other long-term prospective studies do not demonstrate a simple causal link. Interpretation requires caution: risk and impact depend on the duration and severity of hypoglycemia, the person's cardiometabolic profile, and confounding factors such as pre-existing cardiovascular disease or concomitant medications. For the general public, the practical conclusion is that hypoglycemia is a clinically relevant event for those taking insulin or certain medications, and that monitoring and personalized therapy are useful tools to reduce its impact on the heart.

Clinical evidence and significant studies

Research linking hypoglycemia to changes in heart rhythm includes controlled studies, observational studies, and analyses in experimental models. Studies with simultaneous monitoring of interstitial glycemia and ECG have observed an increase in bradycardia and ectopic beats during nocturnal hypoglycemic episodes in patients with diabetes and cardiovascular risk factors [1]. Research on young people with type 1 diabetes has shown that the probability of arrhythmias and electrocardiogram changes vary between daytime and nocturnal hypoglycemia, with a generally more prolonged profile during sleep [2]. More recent investigations, with extended monitoring and rhythm implants, have evaluated the relationship between glycemic variability, hypoglycemia, and arrhythmias in populations with type 2 diabetes on insulin treatment: the results are heterogeneous, and in some samples, a simple association between hypoglycemia and clinically relevant arrhythmias has not been demonstrated, suggesting that the risk depends on the clinical context and the duration of monitoring [3].

Meta-analyses and overall view

Systematic analyses and meta-analyses of clinical and observational studies document an overall association between hypoglycemia and an increased incidence of ECG changes and arrhythmias, as well as an increase in cardiovascular risks and mortality in some large epidemiological studies [4]. These syntheses highlight the evidence of a statistical relationship but also call for caution: numerous confounding factors (comorbidities, disease severity, therapies) make it difficult to draw conclusions of direct causality without further targeted prospective studies.

Plausible biological mechanisms

There are multiple biological explanations that can link low glucose levels to changes in heart rhythm. Among the most recognized mechanisms are: acute sympatho-adrenergic activation followed, in prolonged cases, by vagal responses (with potential bradycardia effect), electrolyte imbalances (particularly hypokalemia induced by insulin infusion), and alterations in cardiac repolarization that can predispose to QT prolongation and ventricular arrhythmias. Animal studies have shown that severe hypoglycemia can cause potentially fatal arrhythmias mediated by the sympatho-adrenergic system; in certain models, preventing the adrenergic response reduces fatal events, confirming a causal role at least in experimental contexts [5].

Why is night different?

During sleep, the adrenergic response to low glucose levels is attenuated: this means that normal warning signs (tremor, sweating, palpitations) may be less evident and that the hypoglycemic episode can persist. The balance between reduced initial sympathetic stimulation and prolonged vagal reactivation can favor bradycardia and specific nocturnal arrhythmias. Continuous glucose monitoring has documented that nocturnal episodes tend to be longer and less perceived than daytime ones [6].

What it means in practice

For people with diabetes (both type 1 and type 2) who receive insulin or hypoglycemic medications, hypoglycemia remains an important clinical event. Modern clinical practice is based on three principles: recognition, prevention, and personalization of therapy. Recognition also involves the use of monitoring technologies (CGM - continuous glucose monitoring) that increase the identification of asymptomatic episodes, especially nocturnal ones. Prevention is based on individual therapeutic adjustments (insulin dose and timing, choice of drugs with lower hypoglycemic risk) and behavioral measures (regular meals, attention to physical exercise and alcohol). Personalization takes into account age, cardiovascular comorbidities, the presence of autonomic neuropathy, and a history of severe hypoglycemia; there are no universal recommendations valid for everyone: each strategy should be discussed with the treating physician.

Limitations of the evidence

It is important to distinguish between observed association and proof of causality: most clinical research on hypoglycemia and cardiac alterations are observational studies or small studies with intensive monitoring. These designs allow for the identification of temporal correlations but are sensitive to confounding (for example: more fragile individuals may have a higher risk of both hypoglycemia and cardiovascular events). Some experimental and animal studies provide plausible biological mechanisms, but their direct translation to humans requires caution. Methodological differences between studies (definitions of hypoglycemia, CGM thresholds, duration and quality of ECG monitoring) limit comparability. Finally, the results show heterogeneity between groups (T1 vs T2, patients with and without heart disease), which emphasizes the need to interpret data in the individual clinical context.

KEY POINTS TO REMEMBER

• Hypoglycemia can alter autonomic control and cardiac electrophysiology, with possible onset of bradycardia and arrhythmias in some patients.
• Nocturnal episodes are often longer and less symptomatic, which is why continuous monitoring is useful for identifying them.
• There is an association between hypoglycemia and an increase in some cardiovascular outcomes in observational studies; direct causality is not always proven.
• The risk is greater in people with cardiovascular risk factors, autonomic neuropathy, or those treated with drugs that promote hypoglycemia.
• Management must be personalized: monitoring, therapeutic choice, and dialogue with the doctor are essential.

Editorial conclusion

Current evidence indicates that hypoglycemia is a significant event for heart health as well: the rhythm alterations recorded during hypoglycemic episodes, especially nocturnal ones, warrant clinical attention, adequate monitoring, and an individualized therapeutic approach. However, the complexity of the evidence requires caution in drawing definitive conclusions about causality for the general population. For people with diabetes, the priority remains the prevention of severe hypoglycemia through thoughtful therapy choices, appropriate use of monitoring technologies, and shared discussion with the treating physician. Future research should clarify which subgroups are truly at increased risk of serious arrhythmic events and which interventions demonstrably reduce the risk of adverse outcomes.

EDITORIAL NOTE

This article was originally published in the past and has been updated following scientific and divulgative criteria for clarity and accuracy. The content is for informational purposes only and does not replace medical advice. For therapeutic decisions or health problems, contact your doctor or a specialized reference center.

SCIENTIFIC RESEARCH

1. Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, Sheridan PJ, Heller SR. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63(5):1738-1747. https://doi.org/10.2337/db13-0468
2. Novodvorsky P, Bernjak A, Chow E, Iqbal A, Sellors L, Williams S, et al. Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care. 2017;40:655–662. https://doi.org/10.2337/dc16-2177
3. Andersen A, Bagger JI, Baldassarre MPA, Christensen MB, Abelin KU, Faber J, et al. Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study. Cardiovasc Diabetol. 2021;20:241. https://doi.org/10.1186/s12933-021-01425-0
4. Fitzpatrick C, Chatterjee S, Seidu S, et al. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2018;20(9):2169–2178. https://doi.1111/dom.13348
5. Reno CM, Daphna‑Iken D, Chen YS, et al. Severe hypoglycemia‑induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes. 2013;62(10):3570–3581. https://doi.org/10.2337/db13-0216
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33(5):1004–1008. https://doi.org/10.2337/dc09-2081
7. Frier BM. The consequences of hypoglycaemia. Diabetologia. 2021;64:963–970. https://doi.org/10.1007/s00125-020-05366-3
8. ACCORD Study Group. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. https://doi.org/10.1136/bmj.b4909

All listed research has been verified for DOI and relevance according to editorial criteria. For further bibliographic information, consult your doctor or a specialized scientific library.